Literature DB >> 23467203

A possible interaction between systemic and renal angiotensinogen in the control of blood pressure.

Nirupama Ramkumar1, Deborah Stuart, Jian Ying, Donald E Kohan.   

Abstract

BACKGROUND: Angiotensinogen (AGT) is synthesized in the liver and proximal tubule. AGT overexpression at either site might increase blood pressure (BP). We used transgenic mice with AGT overexpression in proximal tubule (K), liver (L), or both sites (KL) to determine the relative contributions of hepatic- and proximal tubule-derived AGT in modulating BP.
METHODS: Hepatic AGT overexpression was obtained using the albumin enhancer promoter; the kidney androgen protein gene was used for proximal tubule AGT overexpression. BP and renin angiotensin system parameters were examined in male KL, K, L, and wild-type mice on normal and high-sodium diets.
RESULTS: Compared with wild-type mice, K and KL mice had higher BP on normal and high-sodium diets. L mice had similar BP to wild-type mice on a normal-sodium diet, but high sodium intake caused hypertension. There were no differences in plasma AGT, plasma renin concentration, urine volume, or urine sodium excretion between the groups. Urine AGT and angiotensin II (Ang II) excretion were higher in KL and K mice than in L or wild-type mice on a normal-sodium diet and increased with high sodium intake. During high sodium intake, urine AGT and Ang II were higher in all transgenic mice vs wild-type mice.
CONCLUSIONS: Mice with liver AGT overexpression manifest salt-sensitive hypertension, whereas mice with renal AGT overexpression are hypertensive regardless of salt intake. Systemic AGT may stimulate endogenous renal AGT synthesis during high sodium intake, leading to hypertension in L mice. This suggests that systemic and renal AGT may interact to modulate BP.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23467203      PMCID: PMC3626041          DOI: 10.1093/ajh/hps078

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  25 in total

1.  Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension.

Authors:  H Kobori; L M Harrison-Bernard; L G Navar
Journal:  Hypertension       Date:  2001-05       Impact factor: 10.190

2.  Angiotensin II stimulation of Na(+)-H+ exchange in proximal tubule cells.

Authors:  G Saccomani; K D Mitchell; L G Navar
Journal:  Am J Physiol       Date:  1990-05

Review 3.  Kinetics of the renin system. The basis for determination of the different components of the system.

Authors:  K Poulsen
Journal:  Scand J Clin Lab Invest Suppl       Date:  1973

4.  Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice.

Authors:  O Smithies; H S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

5.  Multiphoton imaging of the glomerular permeability of angiotensinogen.

Authors:  Daisuke Nakano; Hiroyuki Kobori; James L Burford; Haykanush Gevorgyan; Saskia Seidel; Hirofumi Hitomi; Akira Nishiyama; Janos Peti-Peterdi
Journal:  J Am Soc Nephrol       Date:  2012-09-20       Impact factor: 10.121

6.  Effects of dietary sodium and genetic background on angiotensinogen and Renin in mouse.

Authors:  Pierre Lantelme; Andreas Rohrwasser; Barbu Gociman; Elaine Hillas; Tong Cheng; Gray Petty; Jennifer Thomas; Sha Xiao; Tomoaki Ishigami; Tracy Herrmann; Daniel A Terreros; Kenneth Ward; Jean-Marc Lalouel
Journal:  Hypertension       Date:  2002-05       Impact factor: 10.190

7.  Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors.

Authors:  János Peti-Peterdi; David G Warnock; P Darwin Bell
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

8.  Increased blood pressure in transgenic mice expressing both human renin and angiotensinogen in the renal proximal tubule.

Authors:  Julie L Lavoie; Kristy D Lake-Bruse; Curt D Sigmund
Journal:  Am J Physiol Renal Physiol       Date:  2004-01-13

9.  Is angiotensinogen a renin inhibitor and not the substrate for renin?

Authors:  K Poulsen; J Jacobsen
Journal:  J Hypertens       Date:  1986-02       Impact factor: 4.844

10.  Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension.

Authors:  Hiroyuki Kobori; Akira Nishiyama; Lisa M Harrison-Bernard; L Gabriel Navar
Journal:  Hypertension       Date:  2003-01       Impact factor: 10.190

View more
  7 in total

Review 1.  Increased susceptibility of sepsis associated with CD143 deletion/insertion polymorphism in Caucasians: a meta analysis.

Authors:  Hongming Yang; Yihe Wang; Lingying Liu; Quan Hu
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

2.  Liver involvement in early autosomal-dominant polycystic kidney disease.

Authors:  Marie C Hogan; Kaleab Abebe; Vicente E Torres; Arlene B Chapman; Kyongtae T Bae; Cheng Tao; Hongliang Sun; Ronald D Perrone; Theodore I Steinman; William Braun; Franz T Winklhofer; Dana C Miskulin; Frederic Rahbari-Oskoui; Godela Brosnahan; Amirali Masoumi; Irina O Karpov; Susan Spillane; Michael Flessner; Charity G Moore; Robert W Schrier
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-09       Impact factor: 11.382

Review 3.  The intrarenal generation of angiotensin II is required for experimental hypertension.

Authors:  Jorge F Giani; Kandarp H Shah; Zakir Khan; Ellen A Bernstein; Xiao Z Shen; Alicia A McDonough; Romer A Gonzalez-Villalobos; Kenneth E Bernstein
Journal:  Curr Opin Pharmacol       Date:  2015-01-21       Impact factor: 5.547

4.  Relationship between blood pressure variability and renal activity of the renin-angiotensin system.

Authors:  N Ozkayar; F Dede; F Akyel; T Yildirim; I Ateş; T Turhan; B Altun
Journal:  J Hum Hypertens       Date:  2015-07-30       Impact factor: 3.012

5.  Disturbed circadian rhythm of the intrarenal renin-angiotensin system: relevant to nocturnal hypertension and renal damage.

Authors:  Shinsuke Isobe; Naro Ohashi; Tomoyuki Fujikura; Takayuki Tsuji; Yukitoshi Sakao; Hideo Yasuda; Akihiko Kato; Hiroaki Miyajima; Yoshihide Fujigaki
Journal:  Clin Exp Nephrol       Date:  2014-04-12       Impact factor: 2.801

6.  Angiotensin-converting enzyme inhibitor does not suppress renal angiotensin II levels in angiotensin I-infused rats.

Authors:  Keisuke Ohnishi; Miki Murase; Daisuke Nakano; Nicolas Pelisch; Hirofumi Hitomi; Hiroyuki Kobori; Satoshi Morimoto; Hirohito Mori; Tsutomu Masaki; Koji Ohmori; Masakazu Kohno; Atsuhiro Ichihara; Akira Nishiyama
Journal:  J Pharmacol Sci       Date:  2013-05-22       Impact factor: 3.337

7.  Urinary angiotensinogen and urinary sodium are associated with blood pressure in normoalbuminuric children with diabetes.

Authors:  Jolanta Soltysiak; Bogda Skowronska; Piotr Fichna; Danuta Ostalska-Nowicka; Witold Stankiewicz; Maria Lewandowska-Stachowiak; Katarzyna Lipkowska; Jacek Zachwieja
Journal:  Pediatr Nephrol       Date:  2014-06-01       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.